Panorama

Breast cancer recognized as occupational disease for flight attendant Sophie in France

The court in Bayonne has recognized former Air France flight attendant Sophie Lainault's breast cancer as an occupational disease, which may impact other women in the aviation sector.

26 August 2026Tagblick Newsdesk

AI-generatedWritten by an AI system, editorially responsible — how we work

Archive photo: Breast cancer recognized as occupational disease for flight attendant Sophie in France — Archive photoPhoto: Olivier CABARET · Wikimedia Commons · CC BY 2.0

A court in Bayonne, located in southwestern France, has recognized breast cancer in 59-year-old former flight attendant Sophie Lainault as an occupational disease. This marks a first for the French aviation sector, as such a determination had not been made previously.

The court's decision was facilitated by the efforts of Lainault's lawyer, who states that this ruling could pave the way for other female employees in the sector facing similar health issues.

According to the union CFDT, which followed the case, this ruling could also have repercussions for other female staff in the aviation industry should they develop breast cancer as well.

The recognition of breast cancer as an occupational disease may lead to new opportunities for women in aviation, who could potentially be entitled to recognition and support in similar cases.

The significance of this ruling has also been underscored by the attention it has received in various media, including HLN, VRT NWS, and Het Nieuwsblad, which highlighted this milestone.

This ruling could serve as a precedent, furthering the discussion on work-related illnesses within the aviation sector.

This item was written by an AI system on the basis of the headlines and short teasers of the independently operating newsrooms named below. We disclose this under Art. 50(4), second subparagraph, of Regulation (EU) 2024/1689 (AI Act). Before publication we check origin and verifiability — anything that appears in only one place is not published — as well as language, substance and legally sensitive content. No separate substantive review of each individual item by a natural person takes place; we therefore do not rely on the exemption in Art. 50(4), second subparagraph, of the AI Act. Editorial responsibility for this publication rests with the person named in the imprint (§ 18 Abs. 2 MStV). Please report errors to [email protected] — we will correct or remove the item. Full reports are available from the sources listed.